Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 4;3(10):101227.
doi: 10.1016/j.jacadv.2024.101227. eCollection 2024 Oct.

Impact of Residual Transmitral Mean Pressure Gradient on Outcomes After Mitral Transcatheter Edge-to-Edge Repair

Affiliations

Impact of Residual Transmitral Mean Pressure Gradient on Outcomes After Mitral Transcatheter Edge-to-Edge Repair

Yasser M Sammour et al. JACC Adv. .

Abstract

Background: There is conflicting evidence regarding the effect of residual transmitral mean pressure gradient (TMPG) after mitral transcatheter edge-to-edge repair (M-TEER). Different TMPG cutoffs have been employed in prior studies with varying results.

Objectives: The purpose of this study was to examine the association between residual TMPG and M-TEER outcomes.

Methods: Consecutive patients undergoing M-TEER at our institution between 2014 and 2022 were included and divided based on quartiles of predischarge TMPG. Outcomes were assessed using Kaplan-Meier analysis and Cox proportional hazard models. We performed subgroup analyses according to mitral regurgitation (MR) mechanism. The primary outcome was all-cause mortality or heart failure hospitalization.

Results: We included 283 patients (age 76.7 ± 10.8 years, 42.8% women, 78.4% Caucasian, and baseline TMPG 2.4 ± 1.3 mm Hg). Higher baseline TMPG was a predictor of increased TMPG after M-TEER (coefficient 0.60 [95% CI: 0.40-0.70]; P < 0.001). In comparison with predischarge TMPG quartiles 1 to 3, those in quartile 4 (7.0 ± 1.1 mm Hg) had an increased risk of 3-year all-cause mortality or heart failure hospitalization (adjHR: 1.53 [95% CI: 1.03-2.26]; P = 0.034), as well as all-cause mortality alone (adjusted HR [adjHR]: 1.68 [95% CI: 1.09-2.60]; P = 0.020). Among patients with primary MR, similar findings were seen for the composite endpoint (adjHR: 2.08 [95% CI: 1.15-3.77]; P = 0.016), and all-cause mortality (adjHR: 2.70 [95% CI: 1.40-5.19]; P = 0.003). However, this association did not reach statistical significance in secondary MR.

Conclusions: In this single-center study, higher residual TMPG after M-TEER was associated with worse outcomes at intermediate- to long-term follow-up. The effect was mainly driven by increased mortality especially in patients with primary MR. Operators should strive to lower residual TMPG before the conclusion of the procedure.

Keywords: MVG; MitraClip; TEER; TMPG; mean gradient; mitral repair; outcomes.

PubMed Disclaimer

Conflict of interest statement

Dr Atkins is a consultant for WL Gore & Associates. Dr Reardon is a consultant for Medtronic, Boston Scientific, Abbott, and WL Gore & Associates. Dr Kleiman is a local principal investigator in trials sponsored by 10.13039/100008497Boston Scientific, 10.13039/100004374Medtronic, 10.13039/100000046Abbott, and 10.13039/100006520Edwards Lifesciences. Dr Goel is a consultant for Medtronic, WL Gore & Associates, and JC Medical; and is on the Speakers Bureau for Abbott Structural Heart. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Comparison of Baseline, Final Intraprocedural, Discharge, and 30-Day TMPG Among Patients With Different Quartiles of TMPG at Discharge The error bars represent 1 SD around the mean. TMPG = transmitral mean pressure gradient; TTE = transthoracic echocardiogram.
Central Illustration
Central Illustration
Association Between Predischarge TMPG in Quartiles 1 to 4 and Outcomes After M-TEER Impact of transmitral mean pressure gradient (TMPG) on the primary composite outcome of all-cause mortality or heart failure hospitalization at 3 years after M-TEER in (A) all patients; (B) primary mitral regurgitation; and (C) secondary mitral regurgitation. Patients with mixed etiology were excluded from the subgroup analyses shown in (B and C) (N = 15). The panels show adjusted survival analyses stratified by quartiles 1 to 3 versus quartile 4. The variables used for multivariable adjustment are shown in Supplemental Tables 1 to 3. M-TEER = mitral transcatheter edge-to-edge repair.
Figure 2
Figure 2
Comparison of Primary Composite Outcome and Secondary Individual Endpoints After M-TEER According to Quartiles of TMPG The panels show unadjusted Kaplan-Meier curves with overall log-rank P values across the 4 quartiles, as well as the multivariable adjusted HRs comparing quartiles 1 to 3 versus quartile 4. M-TEER = mitral transcatheter edge-to-edge repair; other abbreviation as in Figure 1.
Figure 3
Figure 3
Comparison of Outcomes After M-TEER According to the Mechanism of MR, Including Primary MR and Secondary MR Patients with mixed etiology of mitral regurgitation were excluded from this analysis (N = 15). (A and B) Show unadjusted Kaplan-Meier curves with overall log-rank P values across the 4 quartiles, as well as the multivariable adjusted HRs comparing quartiles 1 to 3 versus quartile 4. MR = mitral regurgitation; other abbreviation as in Figure 2.

References

    1. Feldman T., Foster E., Glower D.D., et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395–1406. - PubMed
    1. Stone G.W., Lindenfeld J., Abraham W.T., et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307–2318. - PubMed
    1. Hahn R.T., Hausleiter J. Transmitral gradients following transcatheter edge-to-edge repair: are mean gradients meaningful? JACC Cardiovasc Interv. 2022;15:946–949. - PubMed
    1. Patzelt J., Zhang W., Sauter R., et al. Elevated mitral valve pressure gradient is predictive of long-term outcome after percutaneous edge-to-edge mitral valve repair in patients with degenerative mitral regurgitation (MR), but not in functional MR. J Am Heart Assoc. 2019;8 - PMC - PubMed
    1. Koell B., Ludwig S., Weimann J., et al. Long-term outcomes of patients with elevated mitral valve pressure gradient after mitral valve edge-to-edge repair. JACC Cardiovasc Interv. 2022;15:922–934. - PubMed

LinkOut - more resources